Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.

about

Nanomedicines for kidney diseases.Innovative Perspective: Gadolinium-Free Magnetic Resonance Imaging in Long-Term Follow-Up after Kidney Transplantation.Contrast-enhanced CT imaging in patients with chronic kidney disease.

P2860

Q38862723-14FE333C-9991-4655-B256-E90F776F89EF Q39339391-F8395402-D10B-466E-A4FB-473FA1AB1EB5 Q48374957-556C1DCC-8E7A-4159-B89E-CD6337ADEE77

P2860

Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.

Item

http://www.wikidata.org/entity/Q36927735

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.

@en

type

Item

label

Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.

@en

prefLabel

Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.

@en

P1476

Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.

@en

P2093

Andrew M Siedlecki

http://www.w3.org/2001/XMLSchema#string

Li-Li Hsiao

http://www.w3.org/2001/XMLSchema#string

Matthew S Chin

http://www.w3.org/2001/XMLSchema#string

Michael L Steigner

http://www.w3.org/2001/XMLSchema#string

Sayeed K Malek

http://www.w3.org/2001/XMLSchema#string

Srinivasan Mukundan

http://www.w3.org/2001/XMLSchema#string

Stefan G Tullius

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Prevalence of chronic kidney disease in the United States

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.

Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study.

The importance of residual renal function in dialysis patients.

Systolic dysfunction portends increased mortality among those waiting for renal transplant

Nephrogenic systemic fibrosis: risk factors and incidence estimation.

Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities.

Vascular Imaging With Ferumoxytol as a Contrast Agent.

P304

984-988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2015.12.017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26786296

http://www.w3.org/2001/XMLSchema#string

P932

4877283

http://www.w3.org/2001/XMLSchema#string

Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.

about

P2860

P2860

Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932